Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study
Johannes Iuel Berg, Sabrina Mai Nielsen, Esben Malm, John P A Ioannidis, Daniel E. Furst, Josef S Smolen, Peter C. Taylor, L. E. Kristensen, Simon Tarp, Torkell Ellingsen, Robin Christensen (2024). Influence of study characteristics on harm estimates from randomised controlled trials in patients with inflammatory arthritis receiving biological or synthetic antirheumatic drugs: a meta-epidemiological study. , 84(3), DOI: https://doi.org/10.1136/ard-2024-226129.
Article147 days agoStakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group
Dorthe B. Berthelsen, Lee S. Simon, John P A Ioannidis, Marieke Voshaar, P. Scott Richards, Niti Goel, Vibeke Strand, Sabrina Mai Nielsen, Beverly Shea, Peter Tugwell, Susan J. Bartlett, Glen Hazlewood, Lyn March, Jasvinder A. Singh, María E. Suarez‐Almazor, Maarten Boers, Randall M. Stevens, Daniel E. Furst, Thasia Woodworth, Amye Leong, Peter Brooks, Caroline Flurey, Robin Christensen (2023). Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group. , 63, DOI: https://doi.org/10.1016/j.semarthrit.2023.152288.
Article147 days agoHarms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group
Dorthe B. Berthelsen, Thasia Woodworth, Niti Goel, John P A Ioannidis, Peter Tugwell, Dan Devoe, Paula Williamson, Caroline B. Terwee, María E. Suarez‐Almazor, Vibeke Strand, Amye Leong, Philip G. Conaghan, Maarten Boers, Beverley Shea, Peter Brooks, Lee S. Simon, Daniel E. Furst, Robin Christensen (2021). Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group. , 51(3), DOI: https://doi.org/10.1016/j.semarthrit.2020.09.023.
Article147 days agoStakeholder Endorsement Advancing the Implementation of a Patient-Reported Domain for Harms in Rheumatology Clinical Trials: Outcome of the Omeract Safety Working Group
Dorthe B. Berthelsen, Lee S. Simon, John P A Ioannidis, Marieke Voshaar, P. Scott Richards, Niti Goel, Vibeke Strand, Sabrina Mai Nielsen, Beverly Shea, Peter Tugwell, Susan J. Bartlett, Glen Hazlewood, Lyn March, Jasvinder A. Singh, María E. Suarez‐Almazor, Maarten Boers, Randall M. Stevens, Daniel E. Furst, Thasia Woodworth, Amye Leong, Peter Brooks, Caroline Flurey, Robin Christiansen, OMERACT Safety Working Group (2023). Stakeholder Endorsement Advancing the Implementation of a Patient-Reported Domain for Harms in Rheumatology Clinical Trials: Outcome of the Omeract Safety Working Group. , DOI: https://doi.org/10.2139/ssrn.4557532.
Preprint147 days agoRisk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors
Esben Malm, Sabrina Mai Nielsen, Johannes Berg, John P A Ioannidis, Daniel E. Furst, Josef S Smolen, Peter C. Taylor, Lars Erik Kristensen, Simon Tarp, Torkell Ellingsen, Robin Christensen (2021). Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors. , 11(9), DOI: https://doi.org/10.1136/bmjopen-2021-049850.
Article146 days ago